[HTML][HTML] A review on the safety of using JAK inhibitors in dermatology: clinical and laboratory monitoring
C Samuel, H Cornman, A Kambala… - Dermatology and Therapy, 2023 - Springer
Janus kinase (JAK) inhibitors are disease-modifying agents with efficacy in treating a
spectrum of burdensome dermatologic conditions. The US Food and Drug Administration …
spectrum of burdensome dermatologic conditions. The US Food and Drug Administration …
[HTML][HTML] A review of safety outcomes from clinical trials of baricitinib in rheumatology, dermatology and COVID-19
Baricitinib is an oral, selective inhibitor of Janus kinase (JAK) 1/JAK2 that transiently and
reversibly inhibits many proinflammatory cytokines. This mechanism is a key mediator in a …
reversibly inhibits many proinflammatory cytokines. This mechanism is a key mediator in a …
Association of risk of incident venous thromboembolism with atopic dermatitis and treatment with Janus kinase inhibitors: a systematic review and meta-analysis
Importance The risk of venous thromboembolism (VTE) among patients with atopic
dermatitis (AD), especially when receiving treatment with Janus kinase (JAK) inhibitors, is …
dermatitis (AD), especially when receiving treatment with Janus kinase (JAK) inhibitors, is …
[HTML][HTML] Baricitinib safety for events of special interest in populations at risk: analysis from randomised trial data across rheumatologic and dermatologic indications
PC Taylor, T Bieber, R Alten, T Witte, J Galloway… - Advances in …, 2023 - Springer
Abstract Introduction Baricitinib, a Janus kinase (JAK) 1/2 inhibitor, is an approved treatment
for rheumatoid arthritis (RA), atopic dermatitis (AD), and alopecia areata (AA). Further …
for rheumatoid arthritis (RA), atopic dermatitis (AD), and alopecia areata (AA). Further …
Biologics for hidradenitis suppurativa: evolution of the treatment paradigm
CA Maronese, C Moltrasio, G Genovese… - Expert Review of …, 2024 - Taylor & Francis
Introduction Hidradenitis suppurativa (HS) is an autoinflammatory skin disease with a high
unmet need for effective medical management. Clinically, it is characterized by inflammatory …
unmet need for effective medical management. Clinically, it is characterized by inflammatory …
JAK in the [black] box: a dermatology perspective on systemic JAK inhibitor safety
Janus kinase (JAK) inhibitors are immunomodulatory agents with broad potential for use
within dermatology. However, the US Food and Drug Administration has recently placed …
within dermatology. However, the US Food and Drug Administration has recently placed …
Occurrence of inflammatory bowel disease in patients with chronic inflammatory skin diseases: a cohort study
MC Schneeweiss, J Kirchgesner, R Wyss… - British Journal of …, 2022 - academic.oup.com
Background Several studies have linked various chronic inflammatory skin diseases
(CISDs) with inflammatory bowel disease (IBD) in a range of data sources with mixed …
(CISDs) with inflammatory bowel disease (IBD) in a range of data sources with mixed …
[HTML][HTML] Comorbidities in patients with vitiligo: a systematic review and meta-analysis
JH Lee, HJ Ju, JM Seo, A Almurayshid, GM Kim… - Journal of Investigative …, 2023 - Elsevier
Vitiligo has been reported to be associated with a variety of diseases, but it has not been
systematically reviewed. Therefore, we aimed to identify prevalent diseases in patients with …
systematically reviewed. Therefore, we aimed to identify prevalent diseases in patients with …
Incidence of cardiovascular disease and venous thromboembolism in patients with atopic dermatitis
Background Atopic dermatitis (AD) may increase risk for atherothrombotic and
cardiovascular (CV) disease. Objective Determine CV disease and venous …
cardiovascular (CV) disease. Objective Determine CV disease and venous …
The risk of venous thromboembolism in atopic dermatitis: a matched cohort analysis in UK primary care
RB Warren, V Basey, A Lynam, C Curtis… - British Journal of …, 2023 - academic.oup.com
Background Atopic dermatitis (AD) is a common chronic inflammatory skin condition. While
other chronic inflammatory conditions are associated with increased risk of venous …
other chronic inflammatory conditions are associated with increased risk of venous …